The use of convalescent plasma has been dropped from the recommended treatment guidelines for COVID-19, according to a advisory from the Indian Council of Medical Research (ICMR).
About:
Though a trial by the ICMR on 400 patients last year — called the PLACID trial — had found no significant benefit from the use of plasma, it continued to find a place in the recommended guidelines.
Some experts have said the use of such plasma may have even played a role in facilitating new worrisome mutations to the virus.
Dear Student,
You have still not entered your mailing address. Please enter the address where all the study materials will be sent to you. (If applicable).
